Predicting Cardiometabolic Risk in Mild-to-Moderate Obstructive Sleep Apnea: Inflammation vs. Apnea/Hypopnea Index

Predicting Cardiometabolic Risk in Mild-to-Moderate Obstructive Sleep Apnea: Inflammation vs. Apnea/Hypopnea Index

The purpose of the study is to compare the relative contribution of systemic inflammation vs. Obstructive Sleep Apnea (OSA) severity (as measured by Apnea Hypopnea Index) in predicting cardiovascular and metabolic aberrations associated with mild-to-moderate obstructive sleep apnea.

Inclusion Criteria:

• Mild to moderate OSA (5≤ AHI <30)
• BMI ≤ 45
• Age ≥ 18
• Men & Women

Exclusion Criteria:

• AHI ≥ 30
• BMI >45
• Current use of steroids or anti-inflammatory medication
• Diagnosis of insulin dependent diabetes
• Diagnosis of autoimmune disorder
• Shiftwork
• Current use of CPAP